Speciality: Hepatologist
Description:
Welcome to our podcast on clinical insights in hepatology. As liver diseases become increasingly common, hepatologists play a vital role in early diagnosis and management. From non-alcoholic fatty liver disease to viral hepatitis and cirrhosis, advancements in imaging, biomarkers, and minimally invasive procedures are transforming patient care. Today, we highlight the importance of multidisciplinary teamwork, timely intervention, and patient education in improving outcomes. Hepatologists not only address liver-specific issues but also manage related metabolic and systemic conditions. Staying updated with the latest research and treatment guidelines helps clinicians provide better, more personalised care. Remember, a proactive approach in liver health can make a significant difference in a patient’s quality of life. Thanks for listening.
See More Webinars @ Hidoc Webinars
1.
In 18 States, alcohol exclusion laws are still in effect.
2.
Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.
3.
Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer
4.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
5.
Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type
1.
Exploring the Causes and Treatments of Bacterial Keratitis: A Comprehensive Guide
2.
Risk Assessment of Cancer-Associated Thrombotic Events
3.
Preventing Developmental Iron Depletion in Childhood
4.
Risk Assessment of Cancer-Associated Endocrine Disorders
5.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
4.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
5.
Understanding Blood Clotting Disorders
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation